caffeine has been researched along with Supranuclear Palsy, Progressive in 1 studies
Supranuclear Palsy, Progressive: A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to determine comprehensive metabolic changes of caffeine in the serum of patients with parkinsonian disorders including Parkinson's disease (PD), progressive supranuclear palsy (PSP), and multiple system atrophy (MSA) and to compare this with healthy control serum." | 7.96 | Shared Metabolic Profile of Caffeine in Parkinsonian Disorders. ( Daida, K; Fujimaki, M; Funayama, M; Hatano, T; Hattori, N; Imamichi, Y; Ishiguro, Y; Ishikawa, KI; Li, Y; Mori, A; Nanmo, H; Nojiri, S; Oji, Y; Okuzumi, A; Saiki, S; Takeshige-Amano, H; Tsunemi, T; Ueno, SI, 2020) |
| "The objective of this study was to determine comprehensive metabolic changes of caffeine in the serum of patients with parkinsonian disorders including Parkinson's disease (PD), progressive supranuclear palsy (PSP), and multiple system atrophy (MSA) and to compare this with healthy control serum." | 3.96 | Shared Metabolic Profile of Caffeine in Parkinsonian Disorders. ( Daida, K; Fujimaki, M; Funayama, M; Hatano, T; Hattori, N; Imamichi, Y; Ishiguro, Y; Ishikawa, KI; Li, Y; Mori, A; Nanmo, H; Nojiri, S; Oji, Y; Okuzumi, A; Saiki, S; Takeshige-Amano, H; Tsunemi, T; Ueno, SI, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeshige-Amano, H | 1 |
| Saiki, S | 1 |
| Fujimaki, M | 1 |
| Ueno, SI | 1 |
| Li, Y | 1 |
| Hatano, T | 1 |
| Ishikawa, KI | 1 |
| Oji, Y | 1 |
| Mori, A | 1 |
| Okuzumi, A | 1 |
| Tsunemi, T | 1 |
| Daida, K | 1 |
| Ishiguro, Y | 1 |
| Imamichi, Y | 1 |
| Nanmo, H | 1 |
| Nojiri, S | 1 |
| Funayama, M | 1 |
| Hattori, N | 1 |
1 other study available for caffeine and Supranuclear Palsy, Progressive
| Article | Year |
|---|---|
Shared Metabolic Profile of Caffeine in Parkinsonian Disorders.
Topics: Caffeine; Humans; Metabolome; Multiple System Atrophy; Parkinsonian Disorders; Supranuclear Palsy, P | 2020 |